Arndt Hartmann

40.4k total citations
155 papers, 4.8k citations indexed

About

Arndt Hartmann is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Arndt Hartmann has authored 155 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 60 papers in Molecular Biology and 54 papers in Surgery. Recurrent topics in Arndt Hartmann's work include Bladder and Urothelial Cancer Treatments (38 papers), Urinary and Genital Oncology Studies (25 papers) and Cancer Genomics and Diagnostics (22 papers). Arndt Hartmann is often cited by papers focused on Bladder and Urothelial Cancer Treatments (38 papers), Urinary and Genital Oncology Studies (25 papers) and Cancer Genomics and Diagnostics (22 papers). Arndt Hartmann collaborates with scholars based in Germany, United States and Switzerland. Arndt Hartmann's co-authors include Hagen Blaszyk, Ferdinand Hofstaedter, Peter J. Wild, Ruth Knuechel, Wolfgang Dietmaier, Robert Stoehr, Robert Stoehr, Christian Pilarsky, André Rosenthal and Matthias Woenckhaus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Arndt Hartmann

150 papers receiving 4.7k citations

Peers

Countries citing papers authored by Arndt Hartmann

Since Specialization

Citations

This map shows the geographic impact of Arndt Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arndt Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arndt Hartmann more than expected).

Fields of papers citing papers by Arndt Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arndt Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arndt Hartmann. The network helps show where Arndt Hartmann may publish in the future.

Co-authorship network of co-authors of Arndt Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Arndt Hartmann. A scholar is included among the top collaborators of Arndt Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arndt Hartmann. Arndt Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A floating collagen matrix triggers ring formation and stemness characteristics in human colorectal cancer organoids 2025 ·Pathology - Research and Practice ·(unknown), K Huebner, Trevor Dale, (unknown), Maximilian Reichert, Arndt Hartmann, Regine Schneider‐Stock	0
2	Pathologically Tumor-free Resection Margin Distance as a Surrogate Parameter in Primary Vulvar Squamous Cell Cancer: Analysis of a Large Two-Center Patient Cohort 2025 ·Geburtshilfe und Frauenheilkunde ·(unknown), (unknown), (unknown), (unknown), Carol Geppert, Arndt Hartmann, (unknown), Matthias W. Beckmann, Martin C. Koch	0
3	KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer 2021 ·Journal of Personalized Medicine ·(unknown), (unknown), Ralph M. Wirtz, Maximilian C. Kriegmair, Philipp Erben, Karl H. Tully, Veronika Weyerer, Markus Eckstein, Arndt Hartmann, Sebastian Eidt, Felix Wezel, Christian Bolenz, Andrea Tannapfel, Joachim Noldus, Florian Roghmann	12
4	Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2 2018 ·Cancers ·Arnatchai Maiuthed, (unknown), (unknown), (unknown), Julienne K. Muenzner, (unknown), (unknown), Chatchai Chaotham, Arndt Hartmann, Adriana Vial Roehe, (unknown), Pithi Chanvorachote, Regine Schneider‐Stock	26
5	ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ 2016 ·Urologia Internationalis ·Johannes Breyer, Wolfgang Otto, Ralph M. Wirtz, Bernd Wullich, Bastian Keck, Philipp Erben, Maximilian C. Kriegmair, Robert Stoehr, Markus Eckstein, Mark Laible, Kornelia Schlombs, Sebastian Eidt, Stefan Denzinger, Maximilian Burger, Arndt Hartmann	27
6	Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial 2016 ·Annals of Oncology ·Oleg Gluz, C Liedtke, Jens Huober, (unknown), Ronald Kates, Hans Kreipe, Arndt Hartmann, Enrico Pelz, Ramona Erber, Svjetlana Mohrmann, Volker Möbus, Doris Augustin, G. M. Hoffmann, Christoph Thomssen, F. Jänicke, Marion Kiechle, D. Wallwiener, W. Kühn, Ulrike Nitz, Nadia Harbeck	10
7	Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk. 2013 ·PubMed ·Anja Rogler, (unknown), Eileen Socher, Elke Nolte, Sven Wach, Wolf F. Wieland, Ferdinand Hofstädter, Peter J. Goebell, Bernd Wullich, Arndt Hartmann, Robert Stoehr	15
8	SNAI1 Protein Expression is an Independent Negative Prognosticator in Muscle-Invasive Bladder Cancer 2013 ·Annals of Surgical Oncology ·Bastian Keck, Sven Wach, Peter J. Goebell, Frank Kunath, Simone Bertz, Jan Lehmann, Michael Stöckle, Helge Täubert, Bernd Wullich, Arndt Hartmann	10
9	Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy 2013 ·BMC Cancer ·Bastian Keck, Sven Wach, Robert Stoehr, Frank Kunath, Simone Bertz, Jan Lehmann, Michael Stöckle, Helge Täubert, Bernd Wullich, Arndt Hartmann	57
10	Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. 2012 ·PubMed ·Sebastian Rogenhofer, Jörg Ellinger, Philip Kahl, Robert Stoehr, Arndt Hartmann, Dirk G. Engehausen, Wolf‐Ferdinand Wieland, Stefan C. Müller, Ferdinand Hofstädter, Bernhard Walter	32
11	Heat Shock Protein 90-Sheltered Overexpression of Insulin-Like Growth Factor 1 Receptor Contributes to Malignancy of Thymic Epithelial Tumors 2011 ·Clinical Cancer Research ·Marco Breinig, Philipp Mayer, (unknown), Benjamin Goeppert, Mona Malz, Roland Penzel, Olaf Neumann, Arndt Hartmann, Hendrik Dienemann, Giuseppe Giaccone, Peter Schirmacher, Michael Kern, Gabriela Chiosis, Ralf J. Rieker	21
12	EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 overexpression independent prediction of poor prognosis. 2010 ·PubMed ·K. Brunner, Claude Fischer, Oliver Driemel, Arndt Hartmann, Gero Brockhoff, Stephan Schwarz	15
13	The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma 2007 ·Gut ·Claus Hellerbrand, Thomas Amann, Jürgen Schlegel, Peter J. Wild, F Bataille, Thilo Spruß, Arndt Hartmann, Anja‐Katrin Bosserhoff	59
14	Spontaneous rupture of a benign giant adrenal adenoma 2007 ·Apmis ·Stefan Denzinger, Maximilian Burger, Arndt Hartmann, Ferdinand Hofstaedter, Wolf F. Wieland, Roman Ganzer	7
15	Smoking and cancer‐related gene expression in bronchial epithelium and non‐small‐cell lung cancers 2006 ·The Journal of Pathology ·Matthias Woenckhaus, Ludger Klein‐Hitpaß, (unknown), Johannes Merk, Roman Pfeifer, (unknown), Marcus Bettstetter, (unknown), Hagen Blaszyk, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier	123
16	Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder 2005 ·Clinical Cancer Research ·Peter J. Wild, Alexander Herr, Christoph Wissmann, Robert Stoehr, André Rosenthal, Dirk Zaak, Ronald Simon, Ruth Knuechel, Christian Pilarsky, Arndt Hartmann	85
17	Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin‐embedded breast cancer 2005 ·The Journal of Pathology ·Christian Lottner, Stephan Schwarz, (unknown), Arndt Hartmann, Ruth Knuechel, Ferdinand Hofstaedter, Gero Brockhoff	50
18	Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation 2004 ·Clinical Cancer Research ·Peter J. Wild, Albrecht Reichle, Reinhard Andreesen, (unknown), Wolfgang Dietmaier, Josef Rüschoff, Hagen Blaszyk, Ferdinand Hofstädter, Arndt Hartmann	22
19	Early onset bladder cancers show distinct clinical, pathological and molecular features 2004 ·Cancer Research ·Arndt Hartmann, Robert Stoehr, Dirk Zaak, Max M. Burger, Peter J. Wild, (unknown), Ellen C. Zwarthoff, Theodorus van der Kwast, Ferdinand Hofstaedter	2
20	Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage 2004 ·The Journal of Pathology ·Astrid Koehler, Frauke Bataille, (unknown), Petra Ruemmele, (unknown), Hagen Blaszyk, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact